Diabetes affects over 422M people worldwide each year. Given the high level of clinician support and treatment costs associated with this disease, DTx in diabetes products are uniquely positioned to treat patients with diabetes and reduce outcome disparities between rural and urban populations.
DTx solutions, which provide personalized medical recommendations based on individual patient data, are helping ease the burden on patients diagnosed with diabetes among other conditions such as coronary heart disease, cancer, and clinical depression. There has been a growing number of positive evidence regarding the use of this form of treatment, for both preventive care as well as better management of symptoms at home.
Through our in-house healthcare market research expertise, we have compiled key insights for a holistic understanding of the current state of DTx in diabetes and its future growth prospects. Download this report to get a detailed lowdown of: